Stratrix
On the Record · P3 Health Partners

P3 Health Partners acquisitions, on the record

The businesses P3 Health Partners bought and sold, as its annual reports describe them, with the cash it reported paying for acquisitions each year and every deal filing since 2016.

Deals its annual reports describe

BusinessDealWhenValue
Medcore HP
Word for word“By way of example, P3 recently acquired Medcore HP, a licensed health plan under the Knox Keene Act, which subjects the entity to certain capital requirements, licensing or certification, governance controls, utilization review and grievance procedures, among others.” 10-K for 2023
acquisition——
Pahrump operations
Word for word“Other during the year ended December 31, 2023 consisted of (i) interest income offset by (ii) cybersecurity incident loss, (iii) restructuring and other charges, including severance and benefits paid to employees pursuant to workforce reduction plans, (iv) the disposition of our Pahrump operations, (v) expenses for third-party consultants to assist us with the development, implementation, and documentation of new and enhanced internal controls and processes for compliance with Sarbanes-Oxley Section 404(b), (vi) a legal settlement outside of the ordinary course of business, and (vii) valuation allowance on our notes receivable.” 10-K for 2023
divestiture——
two medical practices
Word for word“During the year ended December 31, 2022, the Company acquired two medical practices in separate transactions.” 10-K for 2023
acquisitionDuring the year ended December 31, 2022—
Business Combinations with Foresight Acquisition Corp.
Word for word“Note 1: Organization P3 Health Partners Inc. (“P3”) is a patient-centered and physician-led population health management company and, for accounting purposes, the successor to P3 Health Group Holdings, LLC and its subsidiaries (collectively, “P3 LLC,” and together with P3, the “Company”) after the consummation of a series of business combinations in 2021 with Foresight Acquisition Corp. (the “Business Combinations”).” 10-K for 2023
acquisition2021—
Florida Assets
Word for word“The gain on asset sale, net, of $13.3 million for the year ended December 31, 2024 reflects the sale of the Florida Assets (defined below).” 10-K for 2024
divestiture——
As filedReported in the company's financial data (XBRL), each linked to its filing
Fiscal year endedGoodwill from acquisitions
2020-12-31$130,000
2021-12-02$2.9 million
2022-12-31$5.2 million

Deal filings since 2016

Read from P3 Health Partners’s annual reports (10-K for 2025, 10-K for 2024, 10-K for 2023) and the financial data it files with the SEC, as of 2026-03-26. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.